Amdocs Statistics
Total Valuation
Amdocs has a market cap or net worth of $10.33 billion. The enterprise value is $10.79 billion.
Important Dates
The last earnings date was Wednesday, May 7, 2025, after market close.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | Jun 30, 2025 |
Share Statistics
Amdocs has 112.16 million shares outstanding. The number of shares has decreased by -3.80% in one year.
| Current Share Class | 112.16M |
| Shares Outstanding | 112.16M |
| Shares Change (YoY) | -3.80% |
| Shares Change (QoQ) | -0.82% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 98.41% |
| Float | 109.99M |
Valuation Ratios
The trailing PE ratio is 19.27 and the forward PE ratio is 12.58. Amdocs's PEG ratio is 1.37.
| PE Ratio | 19.27 |
| Forward PE | 12.58 |
| PS Ratio | 2.18 |
| Forward PS | 2.25 |
| PB Ratio | 2.96 |
| P/TBV Ratio | 25.50 |
| P/FCF Ratio | 17.16 |
| P/OCF Ratio | 15.03 |
| PEG Ratio | 1.37 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 11.13, with an EV/FCF ratio of 17.93.
| EV / Earnings | 19.95 |
| EV / Sales | 2.27 |
| EV / EBITDA | 11.13 |
| EV / EBIT | 13.81 |
| EV / FCF | 17.93 |
Financial Position
The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.22.
| Current Ratio | 1.16 |
| Quick Ratio | 0.96 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | 0.77 |
| Debt / FCF | 1.31 |
| Interest Coverage | 27.58 |
Financial Efficiency
Return on equity (ROE) is 15.35% and return on invested capital (ROIC) is 11.26%.
| Return on Equity (ROE) | 15.35% |
| Return on Assets (ROA) | 7.75% |
| Return on Invested Capital (ROIC) | 11.26% |
| Return on Capital Employed (ROCE) | 16.07% |
| Revenue Per Employee | $154,820 |
| Profits Per Employee | $17,628 |
| Employee Count | 30,695 |
| Asset Turnover | 0.75 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Amdocs has paid $110.10 million in taxes.
| Income Tax | 110.10M |
| Effective Tax Rate | 16.83% |
Stock Price Statistics
The stock price has increased by +10.65% in the last 52 weeks. The beta is 0.52, so Amdocs's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | +10.65% |
| 50-Day Moving Average | 87.69 |
| 200-Day Moving Average | 86.89 |
| Relative Strength Index (RSI) | 63.80 |
| Average Volume (20 Days) | 636,283 |
Short Selling Information
| Short Interest | 3.80M |
| Short Previous Month | 3.74M |
| Short % of Shares Out | 4.11% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.95 |
Income Statement
In the last 12 months, Amdocs had revenue of $4.75 billion and earned $541.11 million in profits. Earnings per share was $4.75.
| Revenue | 4.75B |
| Gross Profit | 1.74B |
| Operating Income | 781.63M |
| Pretax Income | 618.21M |
| Net Income | 541.11M |
| EBITDA | 969.67M |
| EBIT | 781.63M |
| Earnings Per Share (EPS) | $4.75 |
Full Income StatementBalance Sheet
The company has $323.75 million in cash and $787.74 million in debt, giving a net cash position of -$463.99 million or -$4.14 per share.
| Cash & Cash Equivalents | 323.75M |
| Total Debt | 787.74M |
| Net Cash | -463.99M |
| Net Cash Per Share | -$4.14 |
| Equity (Book Value) | 3.50B |
| Book Value Per Share | 30.91 |
| Working Capital | 220.71M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $687.40 million and capital expenditures -$85.47 million, giving a free cash flow of $601.93 million.
| Operating Cash Flow | 687.40M |
| Capital Expenditures | -85.47M |
| Free Cash Flow | 601.93M |
| FCF Per Share | $5.37 |
Full Cash Flow StatementMargins
Gross margin is 36.64%, with operating and profit margins of 16.45% and 11.39%.
| Gross Margin | 36.64% |
| Operating Margin | 16.45% |
| Pretax Margin | 13.76% |
| Profit Margin | 11.39% |
| EBITDA Margin | 20.40% |
| EBIT Margin | 16.45% |
| FCF Margin | 12.67% |